West Pharmaceutical Services Return on Tangible Equity 2010-2023 | WST

Current and historical return on tangible equity values for West Pharmaceutical Services (WST) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
West Pharmaceutical Services Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $0.59B $2.76B 22.01%
2023-09-30 $0.56B $2.75B 21.14%
2023-06-30 $0.52B $2.62B 20.39%
2023-03-31 $0.55B $2.65B 22.44%
2022-12-31 $0.59B $2.56B 24.97%
2022-09-30 $0.63B $2.35B 27.95%
2022-06-30 $0.69B $2.30B 31.36%
2022-03-31 $0.69B $2.20B 32.77%
2021-12-31 $0.66B $2.20B 33.71%
2021-09-30 $0.61B $2.07B 33.23%
2021-06-30 $0.52B $1.90B 30.13%
2021-03-31 $0.42B $1.69B 26.17%
2020-12-31 $0.35B $1.71B 22.57%
2020-09-30 $0.31B $1.58B 21.31%
2020-06-30 $0.29B $1.47B 20.32%
2020-03-31 $0.26B $1.36B 19.08%
2019-12-31 $0.24B $1.44B 18.05%
2019-09-30 $0.23B $1.35B 17.70%
2019-06-30 $0.23B $1.31B 18.07%
2019-03-31 $0.22B $1.25B 17.82%
2018-12-31 $0.21B $1.27B 17.17%
2018-09-30 $0.16B $1.23B 13.18%
2018-06-30 $0.15B $1.15B 12.94%
2018-03-31 $0.13B $1.17B 11.59%
2017-12-31 $0.15B $1.15B 13.44%
2017-09-30 $0.19B $1.19B 17.54%
2017-06-30 $0.18B $1.11B 17.02%
2017-03-31 $0.18B $1.04B 18.18%
2016-12-31 $0.14B $0.99B 14.67%
2016-09-30 $0.14B $1.01B 14.46%
2016-06-30 $0.10B $0.98B 11.16%
2016-03-31 $0.09B $0.94B 9.66%
2015-12-31 $0.10B $0.88B 11.38%
2015-09-30 $0.09B $0.85B 11.40%
2015-06-30 $0.12B $0.85B 15.07%
2015-03-31 $0.13B $0.80B 16.46%
2014-12-31 $0.13B $0.81B 15.84%
2014-09-30 $0.12B $0.82B 15.26%
2014-06-30 $0.12B $0.81B 15.44%
2014-03-31 $0.11B $0.77B 15.35%
2013-12-31 $0.11B $0.74B 17.21%
2013-09-30 $0.11B $0.68B 17.97%
2013-06-30 $0.10B $0.62B 16.83%
2013-03-31 $0.08B $0.59B 15.09%
2012-12-31 $0.08B $0.57B 14.92%
2012-09-30 $0.08B $0.56B 15.07%
2012-06-30 $0.08B $0.52B 15.67%
2012-03-31 $0.09B $0.53B 16.40%
2011-12-31 $0.08B $0.49B 14.94%
2011-09-30 $0.06B $0.53B 12.59%
2011-06-30 $0.06B $0.53B 13.20%
2011-03-31 $0.07B $0.49B 14.47%
2010-12-31 $0.07B $0.46B 15.14%
2010-09-30 $0.08B $0.46B 18.88%
2010-06-30 $0.08B $0.41B 19.42%
2010-03-31 $0.08B $0.41B 19.31%
2009-12-31 $0.07B $0.41B 18.96%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $28.373B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.513B 20.18
McKesson (MCK) United States $68.775B 18.41
Cardinal Health (CAH) United States $25.885B 15.56
Align Technology (ALGN) United States $24.450B 49.30
Cooper (COO) United States $19.104B 28.91
Labcorp (LH) United States $17.372B 14.84
Henry Schein (HSIC) United States $9.226B 15.96
DENTSPLY SIRONA (XRAY) United States $6.640B 17.50
Merit Medical Systems (MMSI) United States $4.272B 24.44
STAAR Surgical (STAA) United States $2.521B 79.39
CONMED (CNMD) United States $2.342B 22.05
Patterson (PDCO) United States $2.305B 11.04
Atrion (ATRI) United States $0.709B 36.55
Lifevantage (LFVN) United States $0.078B 12.67
Pro-Dex (PDEX) United States $0.065B 24.53
Biolase (BIOL) United States $0.005B 0.00